(DLB) Dolby Laboratories - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US25659T1079

DLB: Audio, Imaging, Codecs, Cinemas, Servers, Processors

Dolby Laboratories, Inc. is a global leader in audio and imaging technologies, revolutionizing the entertainment industry through its innovative solutions. Founded in 1965 and headquartered in San Francisco, Dolby is renowned for its cutting-edge audio codecs such as AAC and HE-AAC, and immersive technologies like Dolby Atmos and Dolby Vision. Their advancements have set industry standards, enhancing audio and visual experiences across cinema, broadcast, and live events. Beyond their technological prowess, Dolby has established partnerships and a strong market presence, solidifying their role in the global entertainment landscape.

Looking ahead, Dolbys stock is expected to navigate a consolidation phase over the next three months. Technically, the stock is trading above its SMA20 of 74.93 but below SMA50 and SMA200, indicating potential short-term weakness with long-term support. The Average True Range (ATR) of 2.26 suggests moderate volatility, with possible price fluctuations within a narrow range. Support levels may be tested near the SMA200 at 76.53, while resistance could be met around the SMA50 at 79.20.

From a fundamental perspective, Dolbys forward P/E of 18.38 signals market expectations for earnings growth, which may bolster the stock despite current SMA trends. However, the P/B ratio of 2.84 indicates a premium relative to book value, and the P/S ratio of 5.29 suggests a rich valuation compared to industry peers. A return on equity of 10.47% reflects moderate profitability. Overall, the stock is likely to experience sideways movement with potential upside driven by earnings growth and continued demand for immersive technologies.

Additional Sources for DLB Stock

DLB Stock Overview

Market Cap in USD 6,952m
Sector Industrials
Industry Specialty Business Services
GiC Sub-Industry Electronic Components
IPO / Inception 2005-02-17

DLB Stock Ratings

Growth Rating 14.1
Fundamental 48.2
Dividend Rating 57.5
Rel. Strength -9.35
Analysts 4.67/5
Fair Price Momentum 68.26 USD
Fair Price DCF 104.47 USD

DLB Dividends

Dividend Yield 12m 1.64%
Yield on Cost 5y 2.24%
Annual Growth 5y 6.93%
Payout Consistency 86.1%

DLB Growth Ratios

Growth Correlation 3m -75.7%
Growth Correlation 12m 18.2%
Growth Correlation 5y -2.2%
CAGR 5y 6.14%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m -0.95
Alpha -13.37
Beta 0.836
Volatility 27.88%
Current Volume 392.8k
Average Volume 20d 387.9k
What is the price of DLB stocks?
As of April 26, 2025, the stock is trading at USD 75.75 with a total of 392,756 shares traded.
Over the past week, the price has changed by +7.19%, over one month by -7.06%, over three months by -6.21% and over the past year by -3.69%.
Is Dolby Laboratories a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Dolby Laboratories (NYSE:DLB) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.21 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DLB as of April 2025 is 68.26. This means that DLB is currently overvalued and has a potential downside of -9.89%.
Is DLB a buy, sell or hold?
Dolby Laboratories has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy DLB.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for DLB stock price target?
According to ValueRays Forecast Model, DLB Dolby Laboratories will be worth about 76.9 in April 2026. The stock is currently trading at 75.75. This means that the stock has a potential upside of +1.53%.
Issuer Forecast Upside
Wallstreet Target Price 100 32%
Analysts Target Price 100 32%
ValueRay Target Price 76.9 1.5%